KalVista Pharmaceuticals, Inc. announced the appointment of Bethany L. Sensenig to its Board of Directors, effective October 1, 2025. Along with joining the Board, Ms. Sensenig was named a member of the Audit Committee. In connection with this change, Nancy Stuart will step down from the Audit Committee but will remain on the Board and continue her role on the Nominating and Corporate Governance Committee. The Board also approved Ms. Stuart’s appointment to the Compensation Committee.
Health Technology Insights: Versant Diagnostics Expands into Georgia with Partnership with SouthEastern Pathology
Ben Palleiko, Chief Executive Officer of KalVista, expressed his enthusiasm about welcoming Bethany to the Board. He highlighted her extensive financial and operational expertise along with her global commercial experience, emphasizing that her insights will be valuable as KalVista works to bring EKTERLY, the first and only oral on-demand therapy for hereditary angioedema, to patients worldwide.
Health Technology Insights: Rula Health Adds New Chief Revenue, Marketing and People Officers
Bethany L. Sensenig shared her excitement about joining KalVista’s Board at this important stage. She noted that launching EKTERLY presents a rare opportunity to offer a transformative new therapy to people living with hereditary angioedema globally. She looks forward to collaborating with the KalVista team as they continue to build a commercial organization focused on improving patients’ lives.
Ms. Sensenig is a seasoned healthcare executive with over 20 years of leadership experience in finance, corporate strategy, and commercial operations. She currently serves as Chief Financial Officer and Head of Operations at Radius Health, Inc., a biopharmaceutical company focused on bone health. She has held previous roles including CFO and Interim CEO at 9 Meters Biopharma, and CFO and Head of US Operations at Minovia Therapeutics. Additionally, she spent 13 years at Biogen Inc., rising to Vice President of Finance and Commercial Operations.
Ms. Sensenig holds a Bachelor of Science degree in Accounting and Business Management from Montreat College and an MBA from Western Carolina University. She also serves on the Board of Directors and Audit Committee of Supernus Pharmaceuticals, a commercial-stage pharmaceutical company.
Health Technology Insights: Innovive Health Opens New Iowa Office for Homecare Services
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
